Fate Therapeutics Inc (NASDAQ:FATE)

2.12
Delayed Data
As of Sep 29
 -0.06 / -2.75%
Today’s Change
1.99
Today|||52-Week Range
23.96
-78.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Redmile Group Llc
Director
Sale4/14/2023302,339$5.84$1.8M-64.73%
Redmile Group Llc
Director
Buy4/21/2023256,639$6.18$1.6M-65.92%
Mendlein John D
Director
Buy1/11/202388,048$5.67$499.2K-62.94%
Wolchko J Scott
President & Chief Executive Officer
Sale1/10/202345,907$5.24$240.6K-61.38%
Mendlein John D
Director
Buy1/13/202336,631$5.43$198.9K-60.74%
Redmile Group Llc
Director
Buy4/14/202325,700$6.00$154.2K-64.73%
Redmile Group Llc
Director
Buy4/20/202320,000$5.99$119.8K-64.67%
Tahl Cindy R
Secretary & General Counsel
Sale1/10/202311,553$5.24$60.5K-61.38%
Valamehr Bahram
Chief Research & Development Officer
Sale1/10/202310,917$5.24$57.2K-61.38%
Chu Yu Waye
Chief Medical Officer
Sale1/10/20237,825$5.24$41.0K-61.38%
Page of 2